2022 price transparency impact report

Turquoise Health's inaugural impact report discussing price transparency regulation, the necessary innovation already happening thanks to third-party organizations, and the various government actions needed for price transparency to fully integrate into the healthcare industry.
Related resources
Learn, listen, and watch the latest on price transparency.

Turquoise's public comment on CMS-1834-P
Turquoise Health's public comment on CMS-1834-P supporting comprehensive hospital MRF standards, seeking clarification on new percentile fields, and providing recommendations on EDI 835 ERA transaction data utility. Read our full analysis.

2025 drug reimbursement trends report
Turquoise Health and ZS's 2025 drug reimbursement trends report analyzes millions of hospital and payer-reported drug rates across 17 products and 4 therapeutic areas revealing how payer-provider dynamics drive reimbursement from 3× to 10× ASP. Explore the data.
